VYGR
Voyager Therapeutics Inc

3,857
Mkt Cap
$231.3M
Volume
398,251.00
52W High
$7.44
52W Low
$2.65
PE Ratio
-1.92
VYGR Fundamentals
Price
$4.09
Prev Close
$4.16
Open
$4.20
50D MA
$4.55
Beta
1.44
Avg. Volume
716,890.39
EPS (Annual)
-$1.13
P/B
1.05
Rev/Employee
$465,122.09
Loading...
Loading...
News
all
press releases
FY2025 Earnings Forecast for VYGR Issued By HC Wainwright
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) - Research analysts at HC Wainwright dropped their FY2025 EPS estimates for Voyager Therapeutics in a report issued on Wednesday, November 12th...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
VYGR FY2025 EPS Forecast Boosted by Cantor Fitzgerald
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) - Equities research analysts at Cantor Fitzgerald increased their FY2025 earnings per share estimates for shares of Voyager Therapeutics in a...
MarketBeat·6d ago
News Placeholder
Research Analysts Offer Predictions for VYGR FY2025 Earnings
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) - Research analysts at Leerink Partnrs lowered their FY2025 earnings per share (EPS) estimates for Voyager Therapeutics in a research report...
MarketBeat·6d ago
News Placeholder
What is Wedbush's Estimate for VYGR FY2025 Earnings?
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) - Stock analysts at Wedbush lifted their FY2025 earnings per share estimates for shares of Voyager Therapeutics in a research report issued to...
MarketBeat·6d ago
News Placeholder
HC Wainwright Issues Pessimistic Forecast for Voyager Therapeutics (NASDAQ:VYGR) Stock Price
HC Wainwright cut their target price on Voyager Therapeutics from $30.00 to $25.00 and set a "buy" rating on the stock in a research note on Wednesday...
MarketBeat·7d ago
News Placeholder
Wedbush Reiterates "Outperform" Rating for Voyager Therapeutics (NASDAQ:VYGR)
Wedbush restated an "outperform" rating and issued a $8.00 target price on shares of Voyager Therapeutics in a report on Tuesday...
MarketBeat·8d ago
News Placeholder
Voyager Therapeutics (NASDAQ:VYGR) Issues Earnings Results, Beats Expectations By $0.06 EPS
Voyager Therapeutics (NASDAQ:VYGR - Get Free Report) issued its earnings results on Monday. The company reported ($0.47) EPS for the quarter, topping the consensus estimate of ($0.53) by $0.06...
MarketBeat·9d ago
News Placeholder
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of +11.32% and +57.01%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Average Recommendation of "Moderate Buy" by Brokerages
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven research firms that are currently covering the company, Marketbeat...
MarketBeat·14d ago
News Placeholder
Moderna (MRNA) Reports Q3 Loss, Tops Revenue Estimates
Moderna (MRNA) delivered earnings and revenue surprises of +76.28% and +18.13%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago

Latest VYGR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.